Gender-based differences in oxidative stress parameters do not underlie the differences in mood disorders susceptibility between sexes

European Psychiatry

Volumn 29, Issue 1, 2014, Pages 58-63

  Wiener, C ^a   Rassier, G T ^a   Kaster, M P ^a   Jansen, K ^a   Pinheiro, R T ^a   Klamt, F ^c   Magalhaes P V ^b   Kapczinski, F ^b   Ghisleni, G ^a   da Silva, R A ^a  

^a CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bipolar disorder; Gender; Major depressive disorder; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LIPID HYDROPEROXIDE; MOOD STABILIZER; URIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; INTERVIEW; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI ITERNATIONAL NEUROPSYCHIATRIC INTERVIEW; OXIDATIVE STRESS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; SEX DIFFERENCE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; URIC ACID BLOOD LEVEL; YOUNG ADULT;

BIPOLAR DISORDER; GENDER; MAJOR DEPRESSIVE DISORDER; OXIDATIVE STRESS;

ADOLESCENT; ADULT; ADVANCED OXIDATION PROTEIN PRODUCTS; BIPOLAR DISORDER; BRAZIL; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; OXIDATIVE STRESS; SEX FACTORS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; URIC ACID; YOUNG ADULT;

EID: 84892508974     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2013.05.006     Document Type: Article

References (44)

1. Aldini G., Orioli M., Carini M. Alpha,beta-unsaturated aldehydes adducts to actin and albumin as potential biomarkers of carbonylation damage. Redox Rep 2007, 12:20-25.
2. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant and radical caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981, 78:6858-6862.
3. Aydin S., Atukeren P., Cakatay U., Uzun H., Altug T. Gender-dependent oxidative variations in liver of aged rats. Biogerontology 2010, 11:335-346.
4. Behr G.A., Moreira J.C.F., Frey B.N. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of Major Depressive Disorder. Ox Med Cell Long 2012, 2012:609421.
5. Block G., Dietrich M., Norkus E.P., Morrow J.D., Hudes M., Caan B., et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002, 156:274-285.
6. Costello E.J., Pine D.S., Hammen C., March J.S., Plotsky P.M., Weissman M.M., et al. Development and natural history of mood disorders. Biol Psychiatry 2002, 52:529-542.
7. Coudray C., Roussel A.M., Mainard F., Arnaud J., Favier A. Lipid peroxidation level and antioxidant micronutrients status in a pré-aging population; correlation with chronic disease prevalence in a French epidemiological study. J Am Coll Nutr 1997, 16:584-591.
8. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003, 9:169-176.
9. Del-Ben C.M., Rodrigues C.R.C., Zuardi A.W. Reliability of a Portuguese version of the structured clinical interview for DSM-III-R (SCID) in a Brazilian sample of outpatient. Braz J Med Biol Res 1996, 29:1675-1682.
10. Evans P.H. Free radicals in brain metabolism and pathology. Br Med Bull 1993, 49:577-587.
11. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992: National Health and Nutrition Examination Survey. JAMA 2000, 283:2404-2410.
12. Fleck M.P., Chaves M.L., Poirier-Littré M.F., Bourdel M.C., Loo H., Guelfi J.D. Depression in France and Brazil: factorial structure of the 17-item Hamilton Depression Scale in inpatients. J Nerv Ment Dis 2004, 192:103-110.
13. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R. Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 2009, 46:241-281.
14. Grande I., Magalhães P.V., Kunz M., Vieta E., Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol Behav 2012, 106:46-50.
15. Grunze H. The clinical side of bipolar disorders. Pharmacopsychiatry 2011, 44:43-48.
16. Hendrick V., Altsuler L.L., Gitlin M.J., Delrahim S., Hammen C. Gender and bipolar illness. J Clin Psychiatr 2000, 61:393-396.
17. Henrique I.F.S., De Micheli D., Lacerda R.B., Lacerda L.A., Formigoni M.L.O.S. Validação da versão brasileira do teste de triagem do envolvimento com álcool, cigarro e outras substâncias (ASSIST). Rev Assoc Med Bras 2004, 50:199-206.
18. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., et al. Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment ofmultiple sclerosis. Proc Natl Acad Sci USA 1997, 94:2528-2533.
19. Ide T., Tsutsui H., Ohashi N., Hayashidani S., Suematsu N., Tsuchihashi M., et al. Greater oxidative stress in healthy Young men compared with premonopausal women. Arterioscler Thromb Vasc Biol 2002, 22:438-442.
20. Jansen K.O.L., Cardoso T.D., Lima R.D., Souza L.D., Magalhaes P.V., et al. Prevalence of episodes of mania and hypomania and associated comorbidities among young adults. J Affect Disord 2010, 130:328-333.
21. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'Anna M., Klamt F., et al. Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 2011, 45:156-161.
22. Kapczinski F., Frey B.N., Andreazza A.C., Kauer-Sant'Anna M., Cunha A.B., Post R.M. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 2008, 3:243-245.
23. Kawa I., Carter J.D., Joyce P.R., Doughty C.J., Frampton C.M., Wells J.E., et al. Gender differences in bipolar disorder: age at onset, course, comorbidity, and symptom presentation. Bipolar Disord 2005, 7:119-125.
24. Kornstein S. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997, 58:12-18.
25. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
26. Lucca G., Comim C.M., Valvassori S.S., Réus G.Z., Vuolo F., Petronilho F., et al. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J Psychiatr Res 2009, 43:864-869.
27. Magalhães P.V., Jansen K., Pinheiro R.T., Colpo G.D., da Motta L.L., Klamt F., et al. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int J Neuropsychopharmacol 2012, 15:1043-1050.
28. Mahadik S.P., Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 1996, 19. 1-17.5.
29. Masahiro I., Shinya A., Masato I., Hiroshi K. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun 2003, 311:1014-1018.
30. Michel T.M., Pülschen D., Thome J. The role of oxidative stress in depressive disorder. Curr Pharm Des 2012, 18:5890-5899.
31. Miguel L., Roncero C., López-Ortiz C., Casas M. Epidemiological and diagnostic axis gender differences in dual diagnosis patients. Adicciones 2011, 23:165-172.
32. Miller A.A., De Silva T.M., Jackman K.A., Sobey C.G. Effect of gender and sex hormones on vascular oxidative stress. Clin Exp Pharmacol Physiol 2007, 10:1037-1043.
33. Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R., Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin Chem 1997, 43:1209-1214.
34. Nivoli A.M., Pacchiarotti I., Rosa A.R., et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord 2011, 133:443-449.
35. Nolen-Hoeksema S., Larson J., Grayson C. Explaining the gender difference in depressive symptoms. J Pers Soc Psychol 1999, 77:1061-1072.
36. Piccinelli M., Wilkinson G. Gender differences in depression: critical review. Br J Psychiatry 2000, 177:486-492.
37. Powers R.W., Majors A.K., Lykins D.L., Sims C.J., Lain K.Y., Roberts J.M. Plasma homocysteine and malondialdehyde are correlated in an age- and gender-specific manner. Metabolism 2002, 51:1433-1438.
38. Sheehan D.V.J.J., Baker R., Harnett-Sheehan K., Knapp E., Sheehan M., et al. MINI-Mini International Neuropsychiatric Interview-English Version 5.0.0-DSM-IV. J Clin Psychiatry 1998, 59:34-57.
39. Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol 1997, 82:291-295.
40. Vilela J.A., Crippa J.A., Del-Ben C.M., Loureiro S.R. Reliability and validity of a Portuguese version of the Young Mania Rating Scale. Braz J Med Biol Res 2005, 38:1429-1439.
41. Vega P., Barbeito S., Azúa S.R., Martínez Cengotitabengoa M., González Ortega I., Saenz M., et al. Bipolar disorder differences between genders: special for women. Womens Health 2011, 7:663-676.
42. Wen S., Cheng M., Wang H., Yue J., Wang H., Li G., et al. Serum uric acid levels and the clinical characteristics of depression. Clin Biochem 2012, 45:49-53.
43. Wills D. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1966, 19:667-676.
44. Zinkevich N.S., Gutterman D.D. ROS-induced ROS release in vascular biology: redox-redox signaling. Am J Physiol Heart Circ Physiol 2011, 301:647-653.